Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders

Drugs

Volumn 66, Issue 9, 2006, Pages 1229-1237

  Goldstein, Benjamin I ^a   Diamantouros, Artemis ^a   Schaffer, Ayal ^a,b   Naranjo, Claudio A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CANNABIS; CLOZAPINE; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUPENTIXOL; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PAROXETINE; QUETIAPINE; QUETIPAINE; RISPERIDONE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INTOXICATION; MEDICAL DECISION MAKING; MENTAL DISEASE; META ANALYSIS; MOOD DISORDER; MORBIDITY; ONSET AGE; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL PHOBIA; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

ALCOHOLISM; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS;

EID: 33745907548     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666090-00005     Document Type: Review

References (64)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511-8
2. Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313-21
3. Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 361-8
4. Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv 2003; 54: 363-9
5. Curran GM, Sullivan G, Williams K, et al. Emergency department use of persons with comorbid psychiatric and substance use disorders. Ann Emerg Med 2003; 41: 659-67
6. Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry 1999; 156: 1230-6
7. Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health 1996; 86: 973-7
8. Woody G. The challenge of dual diagnosis. Alcohol Res Health 1996; 20: 76-80
9. Cornelius JR, Salloum IM, Mezzich J, et al. Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry 1995; 152: 358-64
10. Kosten TR, Kosten TA. New medication strategies for comorbid substance use and bipolar affective disorders. Biol Psychiatry 2004; 56: 771-7
11. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995; 39: 197-206
12. McCloud A, Barnaby B, Omu N, et al. Relationship between alcohol use disorders and suicidality in a psychiatric population. Br J Psychiatry 2004; 184: 439-45
13. Hasin DS, Tsai WY, Endicott J, et al. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord 1996; 41: 63-70
14. Rae AM, Joyce PR, Luty SE, et al. The effect of a history of alcohol dependence in adult major depression. J Affect Disord 2002; 70: 281-90
15. Greenfield SF, Weiss RD, Muenz LR, et al. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 1998; 55: 259-65
16. Mason BJ, Kocsis JH, Ritvo EC, et al. A double-blind, place-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996; 275: 761-7
17. McGrath PJ, Nunes EV, Stewart JW, et al. Imipramine treatment of alcoholics with primary depression. Arch Gen Psychiatry 1996; 53: 232-40
18. Cornelius JR, Salloum IM, Ehler JG, et al. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54: 700-5
19. Roy A. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biol Psychiatry 1998; 44: 633-7
20. Moak DH, Anton RF, Latham PK, et al. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 2003; 23: 553-662
21. Ciraulo DA, Alderson LM, Chapron DJ, et al. Imipramine disposition in alcoholics. J Clin Psychopharmacol 1982; 2: 2-7
22. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence. JAMA 2004; 291: 1887-96
23. Hernandez-Avila CA, Modesto-Lowe V, Feinn R, et al. Nefazodone treatment of comorbid alcohol dependence and major depression. Alcohol Clin Exp Res 2004; 3: 433-40
24. Cornelius JR, Bukstein OG, Birmaher B, et al. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial. Addict Behav 2001; 26: 735-9
25. Cornelius JR, Bukstein OG, Salloum IM, et al. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation. J Child Adolesc Psychopharmacol 2004; 14: 33-8
26. Geller B, Zimerman B, Williams M, et al. Bipolar disorder at prospective follow-up of adults who had a prepubertal major depressive disorder. Am J Psychiatry 2001; 158: 125-7
27. Goldstein BI, Schaffer A, Levitt A, et al. Depressive symptoms and alcohol consumption among non-alcoholic depression patients treated with desipramine. Can J Psychiatry 2004; 49: 859-62
28. Janiri L, Gobbi G, Mannelli P, et al. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. Int Clin Psychopharmacol 1996; 11: 109-17
29. Salloum IM, Cornelius JR, Thase ME, et al. Naltrexone utility in depressed alcoholics. Psychopharmacol Bull 1998; 34: 111-5
30. Salloum IM, Cornelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism. Arch Gen Psychiatry 2005; 62: 37-45
31. Sonne SC, Brady KT. Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence. J Clin Psychopharmacol 2000; 20: 114-5
32. Perugi G, Toni C, Frare F, et al. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol 2002; 22: 584-91
33. Longoria J, Brown ES, Perantie DC, et al. Quetiapine for alcohol use and craving in bipolar disorder. J Clin Psychopharmacol 2004; 24: 101-2
34. Geller B, Cooper TB, Sun K, et al. Double blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc 1998; 37: 171-8
35. Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002; 63: 791-5
36. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association, 1994
37. Kissin B. The use of psychoactive drugs in the long-term treatment of chronic alcoholics. Ann N Y Acad Sci 1975; 252: 385-95
38. Kranzler HR. Evaluation and treatment of anxiety symptoms and disorders in alcoholics. J Clin Psychiatry 1996; 57 Suppl. 7: 15-21
39. Modesto-Lowe V, Kranzler HR. Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders. Alcohol Res Health 1999; 23: 144-9
40. Malcolm R, Anton RF, Randall CL, et al. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 1992; 16: 1007-13
41. Bruno F. Buspirone in the treatment of alcoholic patients. Psychopathology 1989; 22 Suppl. 1: 49-59
42. Tollefson GD, Montague-Clouse J, Tollefson SL. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 1992; 12: 19-26
43. Kranzler HR, Burleson JA, Del Boca FK, et al. Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry 1994; 51: 720-31
44. Lepine JP, Pelissolo A. Social phobia and alcoholism: a complex relationship. J Affect Disord 1998; 50 Suppl. 6: 33-7
45. Randall CL, Johnson MR, Thevos AK, et al. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety 2001; 14: 255-62
46. Reynolds M, Mezey G, Chapman M, et al. Co-morbid posttraumatic stress disorder in a substance misusing clinical population. Drug Alc Dep 2005; 77: 251-8
47. Riggs DS, Rukstalis M, Volpicelli JR, et al. Demographic and social adjustment characteristics of patients with comorbid posttraumatic stress disorder and alcohol dependence: potential pitfalls to PTSD treatment. Addict Behav 2003; 28: 717-30
48. Stewart SH, Pihl RO, Conrod P, et al. Functional association among trauma PTSD and substance-related disorders. Addict Behav 1998; 23: 797-812
49. Chilcoat HD, Breslau N. Post-traumatic stress disorder and drug disorders: testing causal pathways. Arch Gen Psychiatry 1998; 55: 913-7
50. Brady KT, Sonne SC, Roberts JM. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995; 56: 502-5
51. Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of comorbid alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 2005; 29: 395-401
52. Monnelly EP, Ciraulo DA, Knapp C, et al. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 2004; 24: 532-5
53. Sequi J, Marquez M, Canet J, et al. Panic disorder in a Spanish sample of 89 patients with pure alcohol dependence. Drug Alcohol Depend 2001; 63: 117-21
54. Katerndahl DA, Realini JP. Relationship between substance abuse and panic attacks. Addict Behav 1999; 24: 731-6
55. Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 1993; 150: 963-5
56. Brady KT, Sonne S, Lydiard RB. Valproate treatment of comorbid panic disorder and affective disorders in two alcoholic patients. J Clin Psychopharmacol 1994; 14: 81-2
57. Littrell KH, Petty RG, Hilligoss NM, et al. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat 2001; 21: 217-21
58. Hagger R, Brown C, Hurley P. Olanzapine and pancreatitis. Br J Psychiatry 2000; 177: 567
59. Doucette DE, Grenier JP, Robertson PS. Olanzapine-induced acute pancreatitis. Ann Pharmacother 2000; 34: 1128-31
60. Petrakis IL, O'Malley S, Rounsaville B, et al. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology (Berl) 2004; 172: 291-7
61. Soyka M, Aichmuller C, vBardeleben U, et al. Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study. Eur Addict Res 2003; 9: 65-72
62. Green AI, Burgess ES, Dawson R, et al. Alcohol and cannabis use in schizophrenia: effects of clozapine vs risperidone. Schizophr Res 2003; 60: 81-5
63. Drake RE, Xie H, McHugo GH, et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 2000; 26: 441-9
64. Warsi M, Sattar SP, Bhatia SC, et al. Aripiprazole reduces alcohol use. Can J Psychiatry 2005; 50: 244